LexDanaLexDanabeta
Inventor

MITSUNORI KONO

Inventor
JP

Overview

2→
Patents
2023–2025
Patent span
Chemistry
Primary field (CPC C)

Patents· 2 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07DHeterocyclic compounds25%
A61KPreparations for medical, dental or toiletry purposes13%
C07CAcyclic or carbocyclic compounds13%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium13%
C07KPeptides13%
PatentTitleYear
12,247,0153-amino-4H-benzo[e][1,2,4]thiadiazine 1,1-dioxide derivatives as inhibitors of MRGX2202511,851,449Heterocyclic amide compounds having an RORvt inhibitory action2023

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2023Patents assigned to TAKEDA PHARMACEUTICALS CO (1)· patent assignee history
2023–2025Based in JP· patent location history
2025Patents assigned to SOLENT THERAPEUTICS LLC (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
SOLENT THERAPEUTICS LLC12025
TAKEDA PHARMACEUTICALS CO12023
Locations
LocationPatentsSpan
JP22023–2025